Shakur Mohibi

发表

Cancer The 'RBP'eutics - RNA-Binding Proteins as Therapeutic Targets for Cancer.

Xinbin Chen, Shakur Mohibi, Jin Zhang, 2019, Pharmacology & therapeutics.

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

I. Ellis, A. Green, E. Rakha, 2013, Breast Cancer Research and Treatment.

Mice Deficient in the RNA-Binding Protein Zfp871 Are Prone to Early Death and Steatohepatitis in Part through the p53–Mdm2 Axis

Xinbin Chen, Mingyi Chen, Shakur Mohibi, 2021, Molecular Cancer Research.

PABPN1, a target of p63, modulates keratinocyte differentiation through regulation of p63α mRNA translation.

Xinbin Chen, Shakur Mohibi, Jin Zhang, 2020, The Journal of investigative dermatology.

Rbm24, a target of p53, is necessary for proper expression of p53 and heart development

Yanhong Zhang, Xinbin Chen, Shakur Mohibi, 2018, Cell Death & Differentiation.

Acetylation of Mammalian ADA3 Is Required for Its Functional Roles in Histone Acetylation and Cell Proliferation

V. Band, H. Band, S. Mirza, 2016, Molecular and Cellular Biology.

p73α1, an Isoform of the p73 Tumor Suppressor, Modulates Lipid Metabolism and Cancer Cell Growth via Stearoyl-CoA Desaturase-1

O. Fiehn, Xinbin Chen, Shakur Mohibi, 2022, Cells.

ZFP14 Regulates Cancer Cell Growth and Migration by Modulating p53 Protein Stability as Part of the MDM2 E3 Ubiquitin Ligase Complex

Xinbin Chen, Shakur Mohibi, Jin Zhang, 2022, Cancers.

Poly zinc finger protein ZFP14 suppresses lymphomagenesis and abnormal inflammatory response via the HOXA gene cluster

Xinbin Chen, Mingyi Chen, Shakur Mohibi, 2022, Biochimica et biophysica acta. Molecular basis of disease.

Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1–SREBP pathway

Xinbin Chen, Mingyi Chen, Shakur Mohibi, 2022, Oncogene.

Mouse models of estrogen receptor-positive breast cancer

V. Band, H. Band, S. Mirza, 2011, Journal of carcinogenesis.

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients

I. Ellis, A. Green, E. Rakha, 2012, Breast Cancer Research and Treatment.

Alteration/Deficiency in Activation 3 (ADA3) Protein, a Cell Cycle Regulator, Associates with the Centromere through CENP-B and Regulates Chromosome Segregation*

V. Band, H. Band, Xiangshan Zhao, 2015, The Journal of Biological Chemistry.

Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability

B. Dave, T. Pandita, V. Band, 2012, Cell cycle.

ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC

B. Dave, E. Rakha, V. Band, 2016, Breast Cancer Research.

Breast cancer subtypes: two decades of journey from cell culture to patients.

V. Band, H. Band, Xiangshan Zhao, 2011, Advances in experimental medicine and biology.

Mammalian Alteration/Deficiency in Activation 3 (Ada3) Is Essential for Embryonic Development and Cell Cycle Progression*

C. Guda, V. Band, H. Band, 2012, The Journal of Biological Chemistry.

Role of Alteration/Deficiency in Activation (ADA) Complex in Cell Cycle, Genomic Instability and Cancer

V. Band, H. Band, Shakur Mohibi, 2014 .

Epidermal Growth Factor Receptor activation promotes ADA3 acetylation through the AKT-p300 pathway

V. Band, H. Band, S. Mirza, 2017, Cell cycle.

Ferredoxin 1 is essential for embryonic development and lipid homeostasis

Xinbin Chen, Mingyi Chen, Shakur Mohibi, 2023, bioRxiv.

ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC

B. Dave, E. Rakha, V. Band, 2016, Breast Cancer Research.

Measuring Translation Efficiency by RNA Immunoprecipitation of Translation Initiation Factors.

Xinbin Chen, C. Lucchesi, Shakur Mohibi, 2021, Methods in molecular biology.